M&T Bank’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
M&T Bank's AMRX Position: Q3 2026 in Review
M&T Bank increased its Amneal Pharmaceuticals (AMRX) stake by 1.3% in Q3 2026, buying an estimated $5.73K and bringing the position to 24,180 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.
M&T Bank first reported a position in AMRX in Q4 2025 and has held it in 4 quarters since. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- M&T Bank held 24,180 shares of Amneal Pharmaceuticals worth $487K as of Q3 2026.
- M&T Bank bought 318 Amneal Pharmaceuticals shares in Q3 2026, an estimated $5.73K.
- Amneal Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1206 holding.
- M&T Bank first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.